Evaluated by: David B. Kaminsky, M.D., FIAC on May 21, 2017
Original release date: November 17, 2017
Access to this course expires on: May 19, 2020
Faculty: Karim A. Kader, M.D., Ph.D. and Donna Hansel, M.D., Ph.D.
- Describe the clinical impact of grade grouping in prostate cancer
- Understand bladder cancer staging and application to clinical management
- Identify approaches to key challenges in renal pathology
- Understand histological features of germ cell regression in the testis
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
$75.00 - $100.00